chr4-36067919-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015230.4(ARAP2):c.5103G>T(p.Gln1701His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00086 in 1,574,844 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015230.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARAP2 | NM_015230.4 | c.5103G>T | p.Gln1701His | missense_variant | 33/33 | ENST00000303965.9 | NP_056045.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARAP2 | ENST00000303965.9 | c.5103G>T | p.Gln1701His | missense_variant | 33/33 | 1 | NM_015230.4 | ENSP00000302895 | P1 | |
ARAP2 | ENST00000503225.5 | n.147+5770G>T | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000496 AC: 114AN: 229992Hom.: 1 AF XY: 0.000483 AC XY: 60AN XY: 124222
GnomAD4 exome AF: 0.000898 AC: 1278AN: 1422604Hom.: 1 Cov.: 30 AF XY: 0.000891 AC XY: 626AN XY: 702606
GnomAD4 genome AF: 0.000506 AC: 77AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.000537 AC XY: 40AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.5103G>T (p.Q1701H) alteration is located in exon 33 (coding exon 32) of the ARAP2 gene. This alteration results from a G to T substitution at nucleotide position 5103, causing the glutamine (Q) at amino acid position 1701 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at